Targeting eIF4F Translation Complex Sensitizes B-ALL Cells to Tyrosine Kinase Inhibition

In cellular models of Philadelphia Chromosome-positive B-ALL, mTOR kinase inhibitors that inhibit both mTOR-complex-1and mTOR-complex-2 enhanced the cytotoxicity of tyrosine kinase inhibitors such as dasatinib.